Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-03-18 | Tarsus Pharmaceuticals, Inc. | Mottiwala Aziz
(Chief Commercial Officer) |
S | Common Stock | D | 4766 | $30.60 - $30.60 | $145,839 |
| 2024-03-18 | Tarsus Pharmaceuticals, Inc. | Wahl Bryan
(General Counsel) |
S | Common Stock | D | 4436 | $30.60 - $30.60 | $135,741 |
| 2024-03-18 | Tarsus Pharmaceuticals, Inc. | Azamian Bobak R.
(President/CEO and Board Chair) |
S | Common Stock | D | 10415 | $30.60 - $30.60 | $318,699 |
| 2024-03-18 | Tarsus Pharmaceuticals, Inc. | Whitfield Dianne C.
(Chief Human Resources Officer) |
S | Common Stock | D | 4314 | $30.60 - $30.60 | $132,008 |
| 2024-03-18 | Tarsus Pharmaceuticals, Inc. | Neervannan Seshadri
(Chief Operating Officer) |
S | Common Stock | D | 4879 | $30.60 - $30.60 | $149,297 |
| 2023-12-15 | Tarsus Pharmaceuticals, Inc. | Goldberg Andrew D.
(Director) |
P | Common Stock | A | 1000 | $18.96 - $18.96 | $18,960 |
| 2023-11-30 | Tarsus Pharmaceuticals, Inc. | Wahl Bryan
(General Counsel) |
S | Common Stock | D | 8356 | $16.31 - $16.31 | $136,286 |
| 2023-11-29 | Tarsus Pharmaceuticals, Inc. | Wahl Bryan
(General Counsel) |
M | Common Stock | A | 23920 | $0.00 - $0.00 | $0 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |